| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d12b0f56aeb4c6c528c7d3ca3573cdb7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 |
| filingDate |
2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd521e18240b3a00b21a4c397fc28fd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4805ac5c9a84605c5c2a6af3c83a8482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2da8f29389c03930490a703266b0650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c41acf4f173bf2666660ad7f3fb7f346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5298b4c0637b270a6de64fe289ccf16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35114ef898bffe1520cf922001cda918 |
| publicationDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10597410-B2 |
| titleOfInvention |
Intermediates and process for the preparation of a crystalline form of a topical anti-inflammatory agent |
| abstract |
The present invention relates to a process for the preparation of an inhibitor of phosphodiesterase 4, in particular of phosphodiesterase 4B (PDE4B), and intermediates useful for its preparation. |
| priorityDate |
2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |